Incidence of and risk factors for hallucinations and delusions in patients with probable AD.
about
Recognition and Management of Behavioral Disturbances in DementiaLongitudinal course of behavioural and psychological symptoms of dementia: systematic reviewNonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic ReviewPsychosis in Alzheimer's diseaseAbnormal kalirin signaling in neuropsychiatric disorders.Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic reviewPredictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.Organic psychosis: Insight into the biology of psychosis.Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosisAntipsychotic treatments for the elderly: efficacy and safety of aripiprazole.Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study.Delusions and hallucinations are associated with worse outcome in Alzheimer diseasePsychosis in elderly patients: classification and pharmacotherapy.New wine in old bottle: late-life psychosisPsychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.Toward a molecular neuropsychiatry of neurodegenerative diseases.Memantine: update on the current evidence.Executive dysfunction in Alzheimer disease.Pharmacology of antipsychotics in the elderly: a focus on atypicals.β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosisNMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Research agenda for DSM-V: diagnostic categories and criteria for neuropsychiatric syndromes in dementia.Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer's disease.Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.Quality indicators for the care of dementia in vulnerable elders.Late life psychosis: assessment and general treatment strategies.Management of the behavioral and psychological symptoms of dementia.The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtypeVascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.Dementia of the Alzheimer type.Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.Diagnosis and treatment of patients with severe Alzheimer's disease.Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
P2860
Q24682986-3AAD5E47-2490-437F-97F4-763DE32C321DQ26739029-54322281-5087-4FF4-8202-E8D17291CEAEQ26773524-999BE95E-B8C7-4676-8933-C44AD2BCAE31Q26824635-CF8CFC43-278E-4C94-B59F-B09039ABE344Q26824648-B1997A22-F3B8-4490-BF17-F6D164B24C2EQ26830556-5F9DD79C-90D7-4065-96D8-0737D16637B5Q30401309-F437303E-9A5B-4114-95C1-05007592B0B8Q30423717-7E69327E-3CDC-4E8A-8CDA-91178124AF93Q30657153-3EC27F7E-3C4D-4870-8637-2E039D2FFA9FQ33248004-AA7BFA58-C54E-47EC-88A4-CA600AFA18D8Q33635801-CC90814B-AD3D-457B-82DD-246274E484D8Q33668661-CECBFE3E-BFEB-40B0-80BB-73F97606F8F9Q33755676-34ABB3D8-4B9D-4BB8-9580-51C4CCF8AE39Q34114062-B3185D71-FADE-4CC9-BA32-D58703600DE9Q34139476-441DC6A2-8F7A-4938-8635-65EE4DEFB667Q34147753-6649BAC5-6A45-42AC-A11D-1A5002275F83Q34400328-1D6BAB00-1FED-49D4-AACA-815EDDD04C5CQ34528084-BE829771-AC12-42DA-84A3-D1776B5EF16CQ34543627-FF93AD63-0A68-440D-82C7-2E58811938ABQ34976609-623114D6-7711-4924-996E-6422B17022D2Q35124987-C8F790A6-49FF-4768-AEEB-261F6D9EE76DQ35189103-FA4E8FB1-6ACE-4532-9E5C-133CA3FBD3D3Q35218769-5374670A-0508-4A5B-BCA1-7FB4315FB976Q35568529-A722F60F-D8A0-4729-B26E-5EC88D18B7A5Q35947399-483EBAB9-8D05-4CC8-85E5-3A1606A0DFE2Q36054553-E2142DF3-5394-460B-9936-AD70A3D2649AQ36310524-89BBE890-0558-4811-ACDD-85E7F7258A43Q36552900-FEF13749-4656-4B14-890E-9B364B7254E4Q36574153-450F6E0D-A8C7-4EC5-814E-685A610A6B5EQ36655627-48EE8188-7018-4CA1-8901-1FE7D9DE3E3BQ36957853-652E0874-27D0-4B06-B3AB-08CDC15DF7F6Q37001182-C490708F-5195-4219-AE32-43C270873AACQ37069043-8B3E9581-6B8D-4DA9-9F82-C794450FE3F0Q37182912-E1B80EA8-21B4-4DC8-B986-A1D8691D01C3Q37183436-12C01083-3F0F-4603-B61F-E1F464CB8642Q37217602-C3C74D97-0EAC-44C2-859B-19E4717C6490Q37219298-F34FAA65-1870-48A7-B0EA-14BE7FA9A90AQ37316813-0CEB350F-11D6-4759-8CD0-04CA3406DF26Q37394085-9CA6BB59-CB52-4D54-BB94-1E04B3C6F85FQ37445941-14DD2984-F4CC-44EE-AE00-5EF771E1B283
P2860
Incidence of and risk factors for hallucinations and delusions in patients with probable AD.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Incidence of and risk factors ...... in patients with probable AD.
@en
type
label
Incidence of and risk factors ...... in patients with probable AD.
@en
prefLabel
Incidence of and risk factors ...... in patients with probable AD.
@en
P2093
P356
P1433
P1476
Incidence of and risk factors ...... s in patients with probable AD
@en
P2093
C R Hofstetter
C Weisstein-Jenkins
D P Salmon
P304
P356
10.1212/WNL.54.10.1965
P407
P577
2000-05-01T00:00:00Z